nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCG2—Tamoxifen—pancreatic cancer	0.0627	0.0728	CbGbCtD
Apixaban—ABCG2—Erlotinib—pancreatic cancer	0.0533	0.0619	CbGbCtD
Apixaban—ABCG2—Irinotecan—pancreatic cancer	0.0481	0.0559	CbGbCtD
Apixaban—ABCG2—Fluorouracil—pancreatic cancer	0.0462	0.0536	CbGbCtD
Apixaban—ABCG2—Docetaxel—pancreatic cancer	0.0353	0.041	CbGbCtD
Apixaban—ABCG2—Sunitinib—pancreatic cancer	0.0351	0.0408	CbGbCtD
Apixaban—CYP3A5—Tamoxifen—pancreatic cancer	0.0347	0.0403	CbGbCtD
Apixaban—CYP2C8—Tamoxifen—pancreatic cancer	0.0334	0.0388	CbGbCtD
Apixaban—CYP1A2—Dacarbazine—pancreatic cancer	0.0325	0.0377	CbGbCtD
Apixaban—CYP3A5—Erlotinib—pancreatic cancer	0.0295	0.0343	CbGbCtD
Apixaban—CYP2C8—Erlotinib—pancreatic cancer	0.0284	0.033	CbGbCtD
Apixaban—CYP2C19—Tamoxifen—pancreatic cancer	0.028	0.0325	CbGbCtD
Apixaban—CYP3A5—Irinotecan—pancreatic cancer	0.0267	0.031	CbGbCtD
Apixaban—ABCG2—Doxorubicin—pancreatic cancer	0.0263	0.0305	CbGbCtD
Apixaban—CYP1A2—Tamoxifen—pancreatic cancer	0.0258	0.03	CbGbCtD
Apixaban—CYP2C8—Fluorouracil—pancreatic cancer	0.0246	0.0286	CbGbCtD
Apixaban—CYP2C9—Tamoxifen—pancreatic cancer	0.0233	0.027	CbGbCtD
Apixaban—ABCB1—Tamoxifen—pancreatic cancer	0.0226	0.0262	CbGbCtD
Apixaban—CYP1A2—Erlotinib—pancreatic cancer	0.022	0.0255	CbGbCtD
Apixaban—CYP3A5—Docetaxel—pancreatic cancer	0.0195	0.0227	CbGbCtD
Apixaban—ABCB1—Gemcitabine—pancreatic cancer	0.0195	0.0226	CbGbCtD
Apixaban—CYP3A5—Sunitinib—pancreatic cancer	0.0194	0.0226	CbGbCtD
Apixaban—ABCB1—Erlotinib—pancreatic cancer	0.0192	0.0223	CbGbCtD
Apixaban—CYP1A2—Fluorouracil—pancreatic cancer	0.019	0.0221	CbGbCtD
Apixaban—ABCB1—Irinotecan—pancreatic cancer	0.0173	0.0202	CbGbCtD
Apixaban—CYP2C9—Fluorouracil—pancreatic cancer	0.0172	0.0199	CbGbCtD
Apixaban—CYP3A4—Tamoxifen—pancreatic cancer	0.0135	0.0157	CbGbCtD
Apixaban—ABCB1—Docetaxel—pancreatic cancer	0.0127	0.0148	CbGbCtD
Apixaban—ABCB1—Sunitinib—pancreatic cancer	0.0127	0.0147	CbGbCtD
Apixaban—CYP3A4—Erlotinib—pancreatic cancer	0.0115	0.0134	CbGbCtD
Apixaban—CYP3A4—Irinotecan—pancreatic cancer	0.0104	0.0121	CbGbCtD
Apixaban—ABCB1—Doxorubicin—pancreatic cancer	0.00948	0.011	CbGbCtD
Apixaban—CYP3A4—Docetaxel—pancreatic cancer	0.00762	0.00885	CbGbCtD
Apixaban—CYP3A4—Sunitinib—pancreatic cancer	0.00758	0.00881	CbGbCtD
Apixaban—CYP3A4—Doxorubicin—pancreatic cancer	0.00568	0.0066	CbGbCtD
Apixaban—Gastrointestinal haemorrhage—Erlotinib—pancreatic cancer	0.000952	0.00684	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Sunitinib—pancreatic cancer	0.000948	0.00681	CcSEcCtD
Apixaban—Liver function test abnormal—Tamoxifen—pancreatic cancer	0.000889	0.00638	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Tamoxifen—pancreatic cancer	0.000867	0.00623	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Tamoxifen—pancreatic cancer	0.000849	0.0061	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Erlotinib—pancreatic cancer	0.00084	0.00603	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Irinotecan—pancreatic cancer	0.000781	0.00561	CcSEcCtD
Apixaban—Gingival bleeding—Epirubicin—pancreatic cancer	0.000769	0.00552	CcSEcCtD
Apixaban—Liver function test abnormal—Sunitinib—pancreatic cancer	0.000761	0.00547	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Gemcitabine—pancreatic cancer	0.000761	0.00546	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Sunitinib—pancreatic cancer	0.000742	0.00533	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Sunitinib—pancreatic cancer	0.000727	0.00522	CcSEcCtD
Apixaban—Transaminases increased—Epirubicin—pancreatic cancer	0.000717	0.00515	CcSEcCtD
Apixaban—Gingival bleeding—Doxorubicin—pancreatic cancer	0.000711	0.00511	CcSEcCtD
Apixaban—Hepatobiliary disease—Erlotinib—pancreatic cancer	0.000694	0.00499	CcSEcCtD
Apixaban—Epistaxis—Erlotinib—pancreatic cancer	0.000692	0.00497	CcSEcCtD
Apixaban—Blood bilirubin increased—Docetaxel—pancreatic cancer	0.000684	0.00491	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Irinotecan—pancreatic cancer	0.000679	0.00488	CcSEcCtD
Apixaban—Haemoglobin—Tamoxifen—pancreatic cancer	0.000669	0.00481	CcSEcCtD
Apixaban—Haemorrhage—Tamoxifen—pancreatic cancer	0.000666	0.00478	CcSEcCtD
Apixaban—Transaminases increased—Doxorubicin—pancreatic cancer	0.000663	0.00476	CcSEcCtD
Apixaban—Haemoglobin—Erlotinib—pancreatic cancer	0.000662	0.00476	CcSEcCtD
Apixaban—Haemorrhage—Erlotinib—pancreatic cancer	0.000659	0.00473	CcSEcCtD
Apixaban—Urinary tract disorder—Erlotinib—pancreatic cancer	0.000651	0.00467	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Fluorouracil—pancreatic cancer	0.00065	0.00467	CcSEcCtD
Apixaban—Connective tissue disorder—Erlotinib—pancreatic cancer	0.000647	0.00465	CcSEcCtD
Apixaban—Urethral disorder—Erlotinib—pancreatic cancer	0.000646	0.00464	CcSEcCtD
Apixaban—Haematemesis—Epirubicin—pancreatic cancer	0.000628	0.00451	CcSEcCtD
Apixaban—Eye disorder—Erlotinib—pancreatic cancer	0.000616	0.00442	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Irinotecan—pancreatic cancer	0.000612	0.00439	CcSEcCtD
Apixaban—Liver function test abnormal—Gemcitabine—pancreatic cancer	0.000611	0.00439	CcSEcCtD
Apixaban—Hepatobiliary disease—Sunitinib—pancreatic cancer	0.000601	0.00432	CcSEcCtD
Apixaban—Epistaxis—Sunitinib—pancreatic cancer	0.000599	0.0043	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Gemcitabine—pancreatic cancer	0.000596	0.00428	CcSEcCtD
Apixaban—Mediastinal disorder—Erlotinib—pancreatic cancer	0.000594	0.00426	CcSEcCtD
Apixaban—Vaginal haemorrhage—Epirubicin—pancreatic cancer	0.000589	0.00423	CcSEcCtD
Apixaban—Haemoptysis—Epirubicin—pancreatic cancer	0.000589	0.00423	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Gemcitabine—pancreatic cancer	0.000583	0.00419	CcSEcCtD
Apixaban—Haematemesis—Doxorubicin—pancreatic cancer	0.000581	0.00417	CcSEcCtD
Apixaban—Haemoglobin—Sunitinib—pancreatic cancer	0.000573	0.00412	CcSEcCtD
Apixaban—Haemorrhage—Sunitinib—pancreatic cancer	0.00057	0.0041	CcSEcCtD
Apixaban—Urinary tract disorder—Sunitinib—pancreatic cancer	0.000563	0.00405	CcSEcCtD
Apixaban—Connective tissue disorder—Sunitinib—pancreatic cancer	0.00056	0.00403	CcSEcCtD
Apixaban—Urethral disorder—Sunitinib—pancreatic cancer	0.000559	0.00402	CcSEcCtD
Apixaban—Haemoptysis—Doxorubicin—pancreatic cancer	0.000545	0.00392	CcSEcCtD
Apixaban—Vaginal haemorrhage—Doxorubicin—pancreatic cancer	0.000545	0.00392	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Docetaxel—pancreatic cancer	0.00054	0.00388	CcSEcCtD
Apixaban—Anaemia—Tamoxifen—pancreatic cancer	0.000536	0.00385	CcSEcCtD
Apixaban—Eye disorder—Sunitinib—pancreatic cancer	0.000533	0.00383	CcSEcCtD
Apixaban—Petechiae—Epirubicin—pancreatic cancer	0.00053	0.00381	CcSEcCtD
Apixaban—Angiopathy—Sunitinib—pancreatic cancer	0.000517	0.00372	CcSEcCtD
Apixaban—Immune system disorder—Sunitinib—pancreatic cancer	0.000515	0.0037	CcSEcCtD
Apixaban—Syncope—Erlotinib—pancreatic cancer	0.000514	0.00369	CcSEcCtD
Apixaban—Mediastinal disorder—Sunitinib—pancreatic cancer	0.000514	0.00369	CcSEcCtD
Apixaban—Loss of consciousness—Erlotinib—pancreatic cancer	0.000504	0.00362	CcSEcCtD
Apixaban—Petechiae—Doxorubicin—pancreatic cancer	0.000491	0.00352	CcSEcCtD
Apixaban—Haematuria—Gemcitabine—pancreatic cancer	0.000486	0.00349	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.000485	0.00348	CcSEcCtD
Apixaban—Rectal haemorrhage—Epirubicin—pancreatic cancer	0.000483	0.00347	CcSEcCtD
Apixaban—Hepatobiliary disease—Gemcitabine—pancreatic cancer	0.000482	0.00346	CcSEcCtD
Apixaban—Epistaxis—Fluorouracil—pancreatic cancer	0.000473	0.0034	CcSEcCtD
Apixaban—Haemoglobin—Irinotecan—pancreatic cancer	0.000472	0.00339	CcSEcCtD
Apixaban—Haemorrhage—Irinotecan—pancreatic cancer	0.00047	0.00337	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Docetaxel—pancreatic cancer	0.000469	0.00337	CcSEcCtD
Apixaban—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.000463	0.00333	CcSEcCtD
Apixaban—Connective tissue disorder—Irinotecan—pancreatic cancer	0.000462	0.00332	CcSEcCtD
Apixaban—Blood bilirubin increased—Epirubicin—pancreatic cancer	0.000461	0.00331	CcSEcCtD
Apixaban—Shock—Erlotinib—pancreatic cancer	0.000461	0.00331	CcSEcCtD
Apixaban—Haemoglobin—Gemcitabine—pancreatic cancer	0.00046	0.0033	CcSEcCtD
Apixaban—Nervous system disorder—Erlotinib—pancreatic cancer	0.000459	0.0033	CcSEcCtD
Apixaban—Anaemia—Sunitinib—pancreatic cancer	0.000459	0.0033	CcSEcCtD
Apixaban—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000458	0.00329	CcSEcCtD
Apixaban—Haemorrhage—Gemcitabine—pancreatic cancer	0.000458	0.00329	CcSEcCtD
Apixaban—Skin disorder—Erlotinib—pancreatic cancer	0.000455	0.00327	CcSEcCtD
Apixaban—Haemoglobin—Fluorouracil—pancreatic cancer	0.000452	0.00325	CcSEcCtD
Apixaban—Urinary tract disorder—Gemcitabine—pancreatic cancer	0.000452	0.00325	CcSEcCtD
Apixaban—Haemorrhage—Fluorouracil—pancreatic cancer	0.00045	0.00323	CcSEcCtD
Apixaban—Connective tissue disorder—Gemcitabine—pancreatic cancer	0.00045	0.00323	CcSEcCtD
Apixaban—Urethral disorder—Gemcitabine—pancreatic cancer	0.000449	0.00322	CcSEcCtD
Apixaban—Rectal haemorrhage—Doxorubicin—pancreatic cancer	0.000447	0.00321	CcSEcCtD
Apixaban—Liver function test abnormal—Docetaxel—pancreatic cancer	0.000433	0.00311	CcSEcCtD
Apixaban—Blood bilirubin increased—Doxorubicin—pancreatic cancer	0.000427	0.00306	CcSEcCtD
Apixaban—Angiopathy—Irinotecan—pancreatic cancer	0.000426	0.00306	CcSEcCtD
Apixaban—Melaena—Epirubicin—pancreatic cancer	0.000426	0.00306	CcSEcCtD
Apixaban—Immune system disorder—Irinotecan—pancreatic cancer	0.000424	0.00305	CcSEcCtD
Apixaban—Breast disorder—Docetaxel—pancreatic cancer	0.000424	0.00305	CcSEcCtD
Apixaban—Mediastinal disorder—Irinotecan—pancreatic cancer	0.000423	0.00304	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Docetaxel—pancreatic cancer	0.000423	0.00304	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.00042	0.00301	CcSEcCtD
Apixaban—Angiopathy—Gemcitabine—pancreatic cancer	0.000415	0.00298	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Docetaxel—pancreatic cancer	0.000414	0.00297	CcSEcCtD
Apixaban—Immune system disorder—Gemcitabine—pancreatic cancer	0.000413	0.00297	CcSEcCtD
Apixaban—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.000412	0.00296	CcSEcCtD
Apixaban—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000408	0.00293	CcSEcCtD
Apixaban—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000404	0.0029	CcSEcCtD
Apixaban—Shock—Sunitinib—pancreatic cancer	0.000399	0.00286	CcSEcCtD
Apixaban—Nervous system disorder—Sunitinib—pancreatic cancer	0.000397	0.00285	CcSEcCtD
Apixaban—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000397	0.00285	CcSEcCtD
Apixaban—Ecchymosis—Epirubicin—pancreatic cancer	0.000394	0.00283	CcSEcCtD
Apixaban—Melaena—Doxorubicin—pancreatic cancer	0.000394	0.00283	CcSEcCtD
Apixaban—Skin disorder—Sunitinib—pancreatic cancer	0.000394	0.00283	CcSEcCtD
Apixaban—Anaemia—Irinotecan—pancreatic cancer	0.000378	0.00271	CcSEcCtD
Apixaban—Anaemia—Gemcitabine—pancreatic cancer	0.000368	0.00264	CcSEcCtD
Apixaban—Syncope—Irinotecan—pancreatic cancer	0.000367	0.00263	CcSEcCtD
Apixaban—Ecchymosis—Doxorubicin—pancreatic cancer	0.000365	0.00262	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Epirubicin—pancreatic cancer	0.000364	0.00261	CcSEcCtD
Apixaban—Diabetes mellitus—Epirubicin—pancreatic cancer	0.000364	0.00261	CcSEcCtD
Apixaban—Anaemia—Fluorouracil—pancreatic cancer	0.000362	0.0026	CcSEcCtD
Apixaban—Loss of consciousness—Irinotecan—pancreatic cancer	0.000359	0.00258	CcSEcCtD
Apixaban—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00035	0.00251	CcSEcCtD
Apixaban—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000349	0.0025	CcSEcCtD
Apixaban—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000342	0.00246	CcSEcCtD
Apixaban—Epistaxis—Docetaxel—pancreatic cancer	0.000341	0.00245	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Doxorubicin—pancreatic cancer	0.000337	0.00242	CcSEcCtD
Apixaban—Diabetes mellitus—Doxorubicin—pancreatic cancer	0.000337	0.00242	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000337	0.00242	CcSEcCtD
Apixaban—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000334	0.0024	CcSEcCtD
Apixaban—Shock—Irinotecan—pancreatic cancer	0.000328	0.00236	CcSEcCtD
Apixaban—Nervous system disorder—Irinotecan—pancreatic cancer	0.000327	0.00235	CcSEcCtD
Apixaban—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000327	0.00235	CcSEcCtD
Apixaban—Haemoglobin—Docetaxel—pancreatic cancer	0.000326	0.00234	CcSEcCtD
Apixaban—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000325	0.00234	CcSEcCtD
Apixaban—Haemorrhage—Docetaxel—pancreatic cancer	0.000325	0.00233	CcSEcCtD
Apixaban—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000321	0.0023	CcSEcCtD
Apixaban—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00032	0.0023	CcSEcCtD
Apixaban—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000319	0.00229	CcSEcCtD
Apixaban—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000319	0.00229	CcSEcCtD
Apixaban—Urethral disorder—Docetaxel—pancreatic cancer	0.000318	0.00229	CcSEcCtD
Apixaban—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000318	0.00229	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.000317	0.00227	CcSEcCtD
Apixaban—Skin disorder—Gemcitabine—pancreatic cancer	0.000316	0.00227	CcSEcCtD
Apixaban—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000313	0.00225	CcSEcCtD
Apixaban—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000313	0.00225	CcSEcCtD
Apixaban—Dizziness—Tamoxifen—pancreatic cancer	0.000313	0.00225	CcSEcCtD
Apixaban—Hypotension—Irinotecan—pancreatic cancer	0.000312	0.00224	CcSEcCtD
Apixaban—Dizziness—Erlotinib—pancreatic cancer	0.00031	0.00222	CcSEcCtD
Apixaban—Hypotension—Gemcitabine—pancreatic cancer	0.000304	0.00218	CcSEcCtD
Apixaban—Eye disorder—Docetaxel—pancreatic cancer	0.000303	0.00218	CcSEcCtD
Apixaban—Hypotension—Fluorouracil—pancreatic cancer	0.000299	0.00215	CcSEcCtD
Apixaban—Hypersensitivity—Sunitinib—pancreatic cancer	0.000299	0.00214	CcSEcCtD
Apixaban—Rash—Tamoxifen—pancreatic cancer	0.000298	0.00214	CcSEcCtD
Apixaban—Dermatitis—Tamoxifen—pancreatic cancer	0.000298	0.00214	CcSEcCtD
Apixaban—Rash—Erlotinib—pancreatic cancer	0.000295	0.00212	CcSEcCtD
Apixaban—Dermatitis—Erlotinib—pancreatic cancer	0.000295	0.00212	CcSEcCtD
Apixaban—Angiopathy—Docetaxel—pancreatic cancer	0.000295	0.00212	CcSEcCtD
Apixaban—Immune system disorder—Docetaxel—pancreatic cancer	0.000293	0.00211	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000293	0.0021	CcSEcCtD
Apixaban—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000293	0.0021	CcSEcCtD
Apixaban—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000292	0.0021	CcSEcCtD
Apixaban—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000288	0.00207	CcSEcCtD
Apixaban—Breast disorder—Epirubicin—pancreatic cancer	0.000286	0.00206	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000285	0.00205	CcSEcCtD
Apixaban—Nausea—Tamoxifen—pancreatic cancer	0.000281	0.00202	CcSEcCtD
Apixaban—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000281	0.00202	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000279	0.00201	CcSEcCtD
Apixaban—Nausea—Erlotinib—pancreatic cancer	0.000278	0.002	CcSEcCtD
Apixaban—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000276	0.00198	CcSEcCtD
Apixaban—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.00027	0.00194	CcSEcCtD
Apixaban—Dizziness—Sunitinib—pancreatic cancer	0.000268	0.00192	CcSEcCtD
Apixaban—Breast disorder—Doxorubicin—pancreatic cancer	0.000265	0.0019	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000264	0.00189	CcSEcCtD
Apixaban—Anaemia—Docetaxel—pancreatic cancer	0.000261	0.00188	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000258	0.00186	CcSEcCtD
Apixaban—Rash—Sunitinib—pancreatic cancer	0.000255	0.00183	CcSEcCtD
Apixaban—Dermatitis—Sunitinib—pancreatic cancer	0.000255	0.00183	CcSEcCtD
Apixaban—Syncope—Docetaxel—pancreatic cancer	0.000254	0.00182	CcSEcCtD
Apixaban—Loss of consciousness—Docetaxel—pancreatic cancer	0.000248	0.00178	CcSEcCtD
Apixaban—Hypersensitivity—Irinotecan—pancreatic cancer	0.000246	0.00177	CcSEcCtD
Apixaban—Nausea—Sunitinib—pancreatic cancer	0.000241	0.00173	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000239	0.00172	CcSEcCtD
Apixaban—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000236	0.00169	CcSEcCtD
Apixaban—Haematuria—Epirubicin—pancreatic cancer	0.000233	0.00167	CcSEcCtD
Apixaban—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000231	0.00166	CcSEcCtD
Apixaban—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000231	0.00166	CcSEcCtD
Apixaban—Epistaxis—Epirubicin—pancreatic cancer	0.00023	0.00165	CcSEcCtD
Apixaban—Shock—Docetaxel—pancreatic cancer	0.000227	0.00163	CcSEcCtD
Apixaban—Nervous system disorder—Docetaxel—pancreatic cancer	0.000226	0.00163	CcSEcCtD
Apixaban—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000226	0.00162	CcSEcCtD
Apixaban—Skin disorder—Docetaxel—pancreatic cancer	0.000224	0.00161	CcSEcCtD
Apixaban—Dizziness—Irinotecan—pancreatic cancer	0.000221	0.00159	CcSEcCtD
Apixaban—Haemoglobin—Epirubicin—pancreatic cancer	0.00022	0.00158	CcSEcCtD
Apixaban—Haemorrhage—Epirubicin—pancreatic cancer	0.000219	0.00157	CcSEcCtD
Apixaban—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000216	0.00155	CcSEcCtD
Apixaban—Hypotension—Docetaxel—pancreatic cancer	0.000216	0.00155	CcSEcCtD
Apixaban—Haematuria—Doxorubicin—pancreatic cancer	0.000215	0.00155	CcSEcCtD
Apixaban—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000215	0.00155	CcSEcCtD
Apixaban—Urethral disorder—Epirubicin—pancreatic cancer	0.000215	0.00154	CcSEcCtD
Apixaban—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000214	0.00153	CcSEcCtD
Apixaban—Epistaxis—Doxorubicin—pancreatic cancer	0.000213	0.00153	CcSEcCtD
Apixaban—Dizziness—Fluorouracil—pancreatic cancer	0.000211	0.00152	CcSEcCtD
Apixaban—Rash—Irinotecan—pancreatic cancer	0.00021	0.00151	CcSEcCtD
Apixaban—Dermatitis—Irinotecan—pancreatic cancer	0.00021	0.00151	CcSEcCtD
Apixaban—Rash—Gemcitabine—pancreatic cancer	0.000205	0.00147	CcSEcCtD
Apixaban—Dermatitis—Gemcitabine—pancreatic cancer	0.000205	0.00147	CcSEcCtD
Apixaban—Eye disorder—Epirubicin—pancreatic cancer	0.000205	0.00147	CcSEcCtD
Apixaban—Haemoglobin—Doxorubicin—pancreatic cancer	0.000204	0.00146	CcSEcCtD
Apixaban—Haemorrhage—Doxorubicin—pancreatic cancer	0.000203	0.00146	CcSEcCtD
Apixaban—Rash—Fluorouracil—pancreatic cancer	0.000202	0.00145	CcSEcCtD
Apixaban—Dermatitis—Fluorouracil—pancreatic cancer	0.000201	0.00145	CcSEcCtD
Apixaban—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.0002	0.00144	CcSEcCtD
Apixaban—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000199	0.00143	CcSEcCtD
Apixaban—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000199	0.00143	CcSEcCtD
Apixaban—Angiopathy—Epirubicin—pancreatic cancer	0.000199	0.00143	CcSEcCtD
Apixaban—Urethral disorder—Doxorubicin—pancreatic cancer	0.000199	0.00143	CcSEcCtD
Apixaban—Nausea—Irinotecan—pancreatic cancer	0.000198	0.00142	CcSEcCtD
Apixaban—Immune system disorder—Epirubicin—pancreatic cancer	0.000198	0.00142	CcSEcCtD
Apixaban—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000197	0.00142	CcSEcCtD
Apixaban—Nausea—Gemcitabine—pancreatic cancer	0.000193	0.00139	CcSEcCtD
Apixaban—Nausea—Fluorouracil—pancreatic cancer	0.00019	0.00136	CcSEcCtD
Apixaban—Eye disorder—Doxorubicin—pancreatic cancer	0.000189	0.00136	CcSEcCtD
Apixaban—Angiopathy—Doxorubicin—pancreatic cancer	0.000184	0.00132	CcSEcCtD
Apixaban—Immune system disorder—Doxorubicin—pancreatic cancer	0.000183	0.00131	CcSEcCtD
Apixaban—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000183	0.00131	CcSEcCtD
Apixaban—Anaemia—Epirubicin—pancreatic cancer	0.000176	0.00127	CcSEcCtD
Apixaban—Syncope—Epirubicin—pancreatic cancer	0.000171	0.00123	CcSEcCtD
Apixaban—Hypersensitivity—Docetaxel—pancreatic cancer	0.00017	0.00122	CcSEcCtD
Apixaban—Loss of consciousness—Epirubicin—pancreatic cancer	0.000168	0.0012	CcSEcCtD
Apixaban—Anaemia—Doxorubicin—pancreatic cancer	0.000163	0.00117	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000161	0.00116	CcSEcCtD
Apixaban—Syncope—Doxorubicin—pancreatic cancer	0.000158	0.00114	CcSEcCtD
Apixaban—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000156	0.00112	CcSEcCtD
Apixaban—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000155	0.00111	CcSEcCtD
Apixaban—Shock—Epirubicin—pancreatic cancer	0.000153	0.0011	CcSEcCtD
Apixaban—Nervous system disorder—Epirubicin—pancreatic cancer	0.000153	0.0011	CcSEcCtD
Apixaban—Dizziness—Docetaxel—pancreatic cancer	0.000153	0.0011	CcSEcCtD
Apixaban—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000152	0.00109	CcSEcCtD
Apixaban—Skin disorder—Epirubicin—pancreatic cancer	0.000151	0.00109	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000149	0.00107	CcSEcCtD
Apixaban—Rash—Docetaxel—pancreatic cancer	0.000145	0.00104	CcSEcCtD
Apixaban—Hypotension—Epirubicin—pancreatic cancer	0.000145	0.00104	CcSEcCtD
Apixaban—Dermatitis—Docetaxel—pancreatic cancer	0.000145	0.00104	CcSEcCtD
Apixaban—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000144	0.00103	CcSEcCtD
Apixaban—Shock—Doxorubicin—pancreatic cancer	0.000142	0.00102	CcSEcCtD
Apixaban—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000141	0.00101	CcSEcCtD
Apixaban—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000141	0.00101	CcSEcCtD
Apixaban—Skin disorder—Doxorubicin—pancreatic cancer	0.00014	0.001	CcSEcCtD
Apixaban—Nausea—Docetaxel—pancreatic cancer	0.000137	0.000984	CcSEcCtD
Apixaban—Hypotension—Doxorubicin—pancreatic cancer	0.000135	0.000966	CcSEcCtD
Apixaban—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000134	0.000965	CcSEcCtD
Apixaban—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000124	0.000893	CcSEcCtD
Apixaban—Hypersensitivity—Epirubicin—pancreatic cancer	0.000115	0.000823	CcSEcCtD
Apixaban—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000106	0.000762	CcSEcCtD
Apixaban—Dizziness—Epirubicin—pancreatic cancer	0.000103	0.000739	CcSEcCtD
Apixaban—Rash—Epirubicin—pancreatic cancer	9.81e-05	0.000705	CcSEcCtD
Apixaban—Dermatitis—Epirubicin—pancreatic cancer	9.8e-05	0.000704	CcSEcCtD
Apixaban—Dizziness—Doxorubicin—pancreatic cancer	9.52e-05	0.000684	CcSEcCtD
Apixaban—Nausea—Epirubicin—pancreatic cancer	9.24e-05	0.000664	CcSEcCtD
Apixaban—Rash—Doxorubicin—pancreatic cancer	9.08e-05	0.000652	CcSEcCtD
Apixaban—Dermatitis—Doxorubicin—pancreatic cancer	9.07e-05	0.000651	CcSEcCtD
Apixaban—Nausea—Doxorubicin—pancreatic cancer	8.55e-05	0.000614	CcSEcCtD
